(CMMB)
0.00
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.00
0.00 (0.00%)
Chemomab Therapeutics Ltd., klinik bosqichdagi biotexnologiya kompaniyasi, AQShda fibrotik va yallig'lanish kasalliklarini davolash uchun terapevtik vositalarni kashf qilish va ishlab chiqishga qaratilgan. Uning asosiy mahsulot nomzodi Nebokitug, CCL24 ning asosiy funksiyasini susaytiradigan insonlashtirilgan monoklonal antitel bo'lib, birlamchi sklerozli xolangit (PSK)ni davolash uchun 2-bosqichli klinik sinovni yakunlagan; va tizimli sklerozni (SSk) davolash uchun 2-bosqichli klinik sinovda. Chemomab Therapeutics Ltd. 2011-yilda tashkil etilgan va Tel-Aviv-Yafo, Isroilda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Adi Mor George Ph.D. | Co-Founder, Chief Scientific Officer, CEO & Executive Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-19 | 6-K | zk2634872.htm |
| 2025-11-21 | 6-K | zk2534057.htm |
| 2025-08-22 | 6-K | zk2533691.htm |
| 2025-08-14 | 6-K | zk2533584.htm |
| 2025-07-25 | 6-K | zk2533479.htm |
| 2025-07-01 | 6-K | zk2533404.htm |
| 2025-05-27 | 6-K | zk2533263.htm |
| 2025-04-15 | 6-K | zk2533017.htm |
| 2025-04-04 | 20-F | zk2532902.htm |
| 2025-03-27 | 6-K | zk2532931.htm |